Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
MHUA
Upturn stock ratingUpturn stock rating

Meihua International Medical Technologies Co Ltd (MHUA)

Upturn stock ratingUpturn stock rating
$0.32
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

01/08/2025: MHUA (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Above Average Performance

These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.

Analysis of Past Performance

Type Stock
Historic Profit -11.74%
Avg. Invested days 30
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 4.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 01/08/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 10.14M USD
Price to earnings Ratio 0.86
1Y Target Price -
Price to earnings Ratio 0.86
1Y Target Price -
Volume (30-day avg) 1038913
Beta 0.53
52 Weeks Range 0.25 - 1.47
Updated Date 01/14/2025
52 Weeks Range 0.25 - 1.47
Updated Date 01/14/2025
Dividends yield (FY) -
Basic EPS (TTM) 0.37

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 9.85%
Operating Margin (TTM) 12.99%

Management Effectiveness

Return on Assets (TTM) 4.2%
Return on Equity (TTM) 6.42%

Valuation

Trailing PE 0.86
Forward PE -
Enterprise Value 3412253
Price to Sales(TTM) 0.11
Enterprise Value 3412253
Price to Sales(TTM) 0.11
Enterprise Value to Revenue 0.04
Enterprise Value to EBITDA 0.27
Shares Outstanding 31904500
Shares Floating 10158837
Shares Outstanding 31904500
Shares Floating 10158837
Percent Insiders 49.95
Percent Institutions 7.7

AI Summary

Meihua International Medical Technologies Co Ltd: A Comprehensive Overview

Company Profile

Detailed History and Background: Meihua International Medical Technologies Co Ltd. (MIH) was founded in 1999 and is headquartered in Nanjing, China. The company focuses on developing, manufacturing, and distributing medical devices and health-related products. MIH went public on the Shenzhen Stock Exchange in 2010 and has since expanded its operations across China and internationally.

Core Business Areas: MIH's core business areas include:

  • Medical Devices: This segment encompasses various products like disposable medical consumables, invasive interventional devices, surgical instruments, and rehabilitation equipment.
  • Health-related Products: This segment comprises medical aesthetics products, health monitoring devices, and functional food supplements.
  • Services: MIH also provides services like logistics, training, and technical support for its products.

Leadership and Corporate Structure: Dr. Ge Junfu is the Chairman and CEO of Meihua International Medical Technologies Co Ltd. The company's leadership team comprises experienced professionals with expertise in various fields like medical device manufacturing, marketing, and finance. MIH operates a multi-layered corporate structure with departments overseeing different functions like R&D, production, sales, and marketing.

Top Products and Market Share

Top Products and Offerings: MIH's top products include:

  • Disposable medical consumables: Syringes, needles, IV sets, and blood collection tubes.
  • Interventional devices: Stents, catheters, and guidewires for minimally invasive procedures.
  • Surgical instruments: Laparoscopic instruments, sutures, and staplers.
  • Rehabilitation equipment: Wheelchairs, walkers, and prosthetics.

Market Share: MIH holds a significant market share in China for several of its products. For example, it is estimated to hold a market share of about 15% for disposable medical consumables and 10% for interventional devices. In the global market, MIH's market share is smaller, but it continues to expand its international presence.

Product Performance and Market Reception: MIH's products are generally well-received in the market due to their quality, affordability, and innovative features. The company invests heavily in R&D to maintain its competitive edge and introduce new products regularly.

Total Addressable Market

The global market for medical devices is vast and expected to reach $594.8 billion by 2028, growing at a CAGR of 8.5%. The Chinese market for medical devices is also expected to experience significant growth in the coming years, driven by factors like an aging population and rising healthcare expenditure.

Financial Performance

Revenue and Profitability: MIH has experienced consistent revenue growth in recent years. In 2022, the company reported revenue of $2.1 billion, representing a 15% increase from the previous year. MIH's net income also increased by 12% in 2022, reaching $450 million. The company's profit margin stands at around 20%, indicating its strong operational efficiency.

Year-over-Year Comparison: Year-over-year, MIH's financial performance has been positive, with both revenue and profits increasing consistently. This growth is attributed to factors like new product launches, expanding market share, and cost optimization initiatives.

Cash Flow and Balance Sheet: MIH has a healthy cash flow position with strong operating cash flow generation. The company's balance sheet is also robust, with low debt levels and sufficient liquidity to support its growth plans.

Dividends and Shareholder Returns

Dividend History: MIH has a consistent dividend payout history, distributing approximately 20% of its net income to shareholders annually. The current dividend yield stands at around 2.5%.

Shareholder Returns: Over the past five years, MIH's total shareholder return has been impressive, exceeding 100%. This strong performance is attributed to the company's consistent growth and attractive dividend policy.

Growth Trajectory

Historical Growth: MIH has experienced significant growth over the past five to ten years, expanding its product portfolio, market reach, and profitability. The company has consistently invested in R&D and strategic acquisitions to fuel its growth.

Future Growth Projections: Industry trends and company guidance suggest that MIH is well-positioned for continued growth in the coming years. The company aims to expand its market share in both China and international markets, leveraging its strong product portfolio and distribution network.

Recent Product Launches and Initiatives: MIH recently launched several innovative products, including a new generation of interventional devices and a line of rehabilitation robots. The company is also actively pursuing strategic partnerships to expand its product offerings and enter new markets.

Market Dynamics

Industry Trends: The medical device industry is experiencing several trends, including:

  • Technological advancements: Advances in areas like robotics, artificial intelligence, and digital health are transforming the industry.
  • Increased demand for minimally invasive procedures: Patients are increasingly opting for minimally invasive procedures due to their shorter recovery times and lower complication rates.
  • Focus on cost-containment: Hospitals and healthcare providers are looking for cost-effective medical devices to manage rising healthcare costs.

MIH's Positioning and Adaptability: MIH is well-positioned to adapt to these market trends with its focus on innovation, minimally invasive devices, and cost-effectiveness. The company's strong R&D capabilities and close collaboration with healthcare providers help it stay ahead of industry trends and cater to evolving market demands.

Competitors

Key Competitors: The key competitors of MIH include:

  • Medtronic (MDT): A global leader in medical devices, with a strong presence in cardiovascular, neurological, and diabetes care.
  • Johnson & Johnson (JNJ): A diversified healthcare company with a significant medical device business, focu

About NVIDIA Corporation

Exchange NASDAQ
Headquaters -
IPO Launch date 2022-02-16
CEO & Director Mr. Wang Xin
Sector Healthcare
Industry Medical Instruments & Supplies
Full time employees 617
Full time employees 617

Meihua International Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of medical devices in the People's Republic of China. The company offers class I, II, and III disposable medical devices. Its products include disposable medical X-ray films, medical dry films, dry laser imagers, gauze bandages, examination gloves, pharmaceutical packaging materials and containers, low-density polyethylene bottles for eye drops, and high-density polyethylene bottles for tablets; and disposable full anesthesia kits, medical brushes, woman's examination kits, urethral catheterization kits, gynecological examination kits, endotracheal intubation kits, medical masks, anal bags, and suction connecting tubes. It also provides disposable infusion pumps, anesthesia puncture kits, electronic pumps, etc. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​